140 related articles for article (PubMed ID: 9072430)
21. Modification of pressure natriuresis by long-term losartan in spontaneously hypertensive rats.
Kline RL; Liu F
Hypertension; 1994 Oct; 24(4):467-73. PubMed ID: 8088913
[TBL] [Abstract][Full Text] [Related]
22. Losartan for hypertension.
Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
[No Abstract] [Full Text] [Related]
23. Relative contribution of angiotensin II, bradykinin, and prostaglandins to the renal effects of converting enzyme inhibition in rats after chronic myocardial infarction.
Deck CC; Gaballa MA; Raya TE
J Cardiovasc Pharmacol; 1996 Jul; 28(1):167-74. PubMed ID: 8797151
[TBL] [Abstract][Full Text] [Related]
24. The effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on obstructed rat bladder.
Palmer LS; Lee C; Decker RS; Lang S; Kaplan WE; Firlit CF; Cheng EY
J Urol; 1997 Sep; 158(3 Pt 2):1100-4. PubMed ID: 9258150
[TBL] [Abstract][Full Text] [Related]
25. Sympathoinhibitory effects of losartan in spontaneously hypertensive rats.
Moreau N; Richer C; Vincent MP; Giudicelli JF
J Cardiovasc Pharmacol; 1993 Jul; 22(1):126-34. PubMed ID: 7690084
[TBL] [Abstract][Full Text] [Related]
26. Losartan in patients with renal insufficiency.
de Zeeuw D; Gansevoort RT; de Jong PE
Can J Cardiol; 1995 Aug; 11 Suppl F():41F-44F. PubMed ID: 7664217
[TBL] [Abstract][Full Text] [Related]
27. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
Zanella MT; Ribeiro AB
Clin Ther; 2002 Jul; 24(7):1019-34. PubMed ID: 12182249
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive therapy and adaptive mechanisms in peripheral ischemia.
Nelissen-Vrancken HJ; Boudier HA; Daemen MJ; Smits JF
Hypertension; 1993 Nov; 22(5):780-8. PubMed ID: 8225538
[TBL] [Abstract][Full Text] [Related]
29. Effects of losartan on cerebral arteries in stroke-prone spontaneously hypertensive rats.
Vacher E; Richer C; Giudicelli JF
J Hypertens; 1996 Nov; 14(11):1341-8. PubMed ID: 8934363
[TBL] [Abstract][Full Text] [Related]
30. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
31. [Losartan and the LIFE-study. Antihypertensive treatment with AT1-receptor antagonist].
Kjeldsen SE; Omvik P
Tidsskr Nor Laegeforen; 1996 Feb; 116(4):504-7. PubMed ID: 8644056
[TBL] [Abstract][Full Text] [Related]
32. Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
Araki M; Kanda T; Imai S; Suzuki T; Murata K; Kobayashi I
J Cardiovasc Pharmacol; 1995 Jul; 26(1):61-5. PubMed ID: 7564367
[TBL] [Abstract][Full Text] [Related]
33. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM
Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure.
Morton JJ; Beattie EC; MacPherson F
J Vasc Res; 1992; 29(3):264-9. PubMed ID: 1387008
[TBL] [Abstract][Full Text] [Related]
35. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
Cody RJ; Binkley PF; Haas GJ; Brown DM
Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
[TBL] [Abstract][Full Text] [Related]
36. ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats.
Nagura J; Hui C; Yamamoto M; Yasuda S; Abe M; Hachisu M; Konno F
Jpn J Pharmacol; 1996 May; 71(1):39-49. PubMed ID: 8791170
[TBL] [Abstract][Full Text] [Related]
37. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
Goldberg AI; Dunlay MC; Sweet CS
Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281
[TBL] [Abstract][Full Text] [Related]
38. [Angiotensin-2 receptor blockade--new therapeutic approach to treatment of hypertension].
Zimlichman R
Harefuah; 1996 Jul; 131(1-2):43-5. PubMed ID: 8854479
[No Abstract] [Full Text] [Related]
39. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
Tikkanen I; Omvik P; Jensen HA
J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus.
Chan JC; Critchley JA; Tomlinson B; Chan TY; Cockram CS
Am J Nephrol; 1997; 17(1):72-80. PubMed ID: 9057957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
